Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2024-02-09 Sale | 2024-02-13 9:31 pm | IO Biotech Inc. | IOBT | Novo Holdings A/S 10% Owner | 658,809 | $1.5003 | $988,411 | 5,088,258 (Direct) | View |
| 2023-11-21 Purchase | 2023-11-24 5:37 pm | IO Biotech Inc. | IOBT | Burkavage Brian Chief Accounting Officer | 10,000 | $1.0125 | $10,125 | 11,500 (Direct) | View |
| 2023-08-09 Purchase | 2023-08-11 4:31 pm | IO Biotech Inc. | IOBT | Novo Holdings A/S 10% Owner | 2,469,135 | $2.025 | $4,999,998 | 8,176,602 (Direct) | View |
| 2023-08-09 Purchase | 2023-08-10 09:03 am | IO Biotech Inc. | IOBT | Vivo Capital IX LLC Vivo Capital Fund IX L.P. Vivo Opportunity LLC Vivo Opportunity Fund Holdings L.P. 10% Owner | 3,157,894 | $1.9 | $5,999,999 | 9,331,333 (Indirect) | View |
| 2023-03-17 Purchase | 2023-03-20 5:35 pm | IO Biotech Inc. | IOBT | Sullivan Amy Chief Financial Officer | 25,000 | $2.3207 | $58,018 | 25,000 (Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2024-03-15 Option Award | 2024-03-18 4:27 pm | N/A 2034-03-15 | IO Biotech Inc. | IOBT | Zocca Mai-Britt Chief Executive Officer | 750,000 | $0 | 750,000 (Direct) | View |
| 2024-03-15 Option Award | 2024-03-18 4:24 pm | N/A 2034-03-15 | IO Biotech Inc. | IOBT | Sullivan Amy Chief Financial Officer | 280,000 | $0 | 280,000 (Direct) | View |
| 2024-03-15 Option Award | 2024-03-18 4:23 pm | N/A 2034-03-15 | IO Biotech Inc. | IOBT | Smith Devin Whittemore General Counsel | 185,000 | $0 | 185,000 (Direct) | View |
| 2024-03-15 Option Award | 2024-03-18 4:22 pm | N/A 2034-03-15 | IO Biotech Inc. | IOBT | Burkavage Brian Chief Accounting Officer | 50,000 | $0 | 50,000 (Direct) | View |
| 2024-03-15 Option Award | 2024-03-18 4:18 pm | N/A 2034-03-15 | IO Biotech Inc. | IOBT | Ahmad Qasim Iftikhar Chief Medical Officer | 280,000 | $0 | 280,000 (Direct) | View |
| 2023-11-15 Option Award | 2023-11-17 4:47 pm | N/A 2033-11-15 | IO Biotech Inc. | IOBT | Collins Helen Louise Director | 64,238 | $0 | 64,238 (Direct) | View |
Ownership | 2023-08-21 3:40 pm | N/A N/A | IO Biotech Inc. | IOBT | Kurma Partners 10% Owner | 0 | $0 | 12,253,230 (Indirect) | View |
| 2023-08-11 Option Award | 2023-08-15 6:02 pm | N/A 2033-08-11 | IO Biotech Inc. | IOBT | Hunter Heidi Director | 64,238 | $0 | 64,238 (Direct) | View |
| 2023-08-09 Option Award | 2023-08-11 9:24 pm | 2023-08-09 N/A | IO Biotech Inc. | IOBT | Elling Christian E Director 10% Owner | 7,901,234 | $0.125 | 21,851,920 (Indirect) | View |
| 2023-08-09 Option Award | 2023-08-11 9:24 pm | N/A N/A | IO Biotech Inc. | IOBT | Elling Christian E Director 10% Owner | 7,901,234 | $1.9 | 21,851,920 (Indirect) | View |
| 2023-08-09 Option Award | 2023-08-11 9:22 pm | 2023-08-09 N/A | IO Biotech Inc. | IOBT | Lundbeckfond Invest A/S Director 10% Owner | 7,901,234 | $0.125 | 21,851,920 (Direct) | View |
| 2023-08-09 Option Award | 2023-08-11 9:22 pm | N/A N/A | IO Biotech Inc. | IOBT | Lundbeckfond Invest A/S Director 10% Owner | 7,901,234 | $1.9 | 21,851,920 (Direct) | View |
| 2023-08-09 Option Award | 2023-08-09 8:43 pm | 2023-08-09 N/A | IO Biotech Inc. | IOBT | Zocca Mai-Britt Chief Executive Officer | 37,037 | $0.125 | 101,008 (Direct) | View |
| 2023-08-09 Option Award | 2023-08-09 8:43 pm | N/A N/A | IO Biotech Inc. | IOBT | Zocca Mai-Britt Chief Executive Officer | 37,037 | $1.9 | 101,008 (Direct) | View |
| 2023-08-09 Option Award | 2023-08-09 8:41 pm | 2023-08-09 N/A | IO Biotech Inc. | IOBT | Sullivan Amy Chief Financial Officer | 49,382 | $0.125 | 123,764 (Direct) | View |
| 2023-08-09 Option Award | 2023-08-09 8:41 pm | N/A N/A | IO Biotech Inc. | IOBT | Sullivan Amy Chief Financial Officer | 49,382 | $1.9 | 123,764 (Direct) | View |
| 2023-08-09 Option Award | 2023-08-09 8:38 pm | 2023-08-09 N/A | IO Biotech Inc. | IOBT | Smith Devin Whittemore General Counsel | 4,938 | $0.125 | 9,876 (Direct) | View |
| 2023-08-09 Option Award | 2023-08-09 8:38 pm | N/A N/A | IO Biotech Inc. | IOBT | Smith Devin Whittemore General Counsel | 4,938 | $1.9 | 9,876 (Direct) | View |
| 2023-07-17 Option Award | 2023-07-19 4:20 pm | N/A 2033-07-17 | IO Biotech Inc. | IOBT | Ahmad Qasim Iftikhar Chief Medical Officer | 288,153 | $0 | 288,153 (Direct) | View |
| 2023-06-08 Option Award | 2023-06-13 7:54 pm | N/A 2033-06-08 | IO Biotech Inc. | IOBT | Smith David V Director | 41,533 | $0 | 41,533 (Direct) | View |
| 2023-06-08 Option Award | 2023-06-13 7:54 pm | N/A 2033-06-08 | IO Biotech Inc. | IOBT | Nielsen Jack Director | 41,533 | $0 | 41,533 (Direct) | View |
| 2023-06-08 Option Award | 2023-06-13 7:54 pm | N/A 2033-06-08 | IO Biotech Inc. | IOBT | Hirth Peter Director | 41,533 | $0 | 41,533 (Direct) | View |
| 2023-06-08 Option Award | 2023-06-13 7:54 pm | N/A 2033-06-08 | IO Biotech Inc. | IOBT | Glaub Kathleen Sereda Director | 41,533 | $0 | 41,533 (Direct) | View |
| 2023-06-08 Option Award | 2023-06-13 7:54 pm | N/A 2033-06-08 | IO Biotech Inc. | IOBT | Elling Christian E Director | 41,533 | $0 | 41,533 (Direct) | View |
| 2023-03-20 Option Award | 2023-03-22 4:40 pm | N/A 2033-03-20 | IO Biotech Inc. | IOBT | Al-Hajj Muhammad Chief Scientific Officer | 120,000 | $0 | 120,000 (Direct) | View |
| 2023-03-20 Option Award | 2023-03-22 4:34 pm | N/A 2033-03-20 | IO Biotech Inc. | IOBT | Zocca Mai-Britt Chief Executive Officer | 500,000 | $0 | 500,000 (Direct) | View |
| 2023-03-20 Option Award | 2023-03-22 4:26 pm | N/A 2033-03-20 | IO Biotech Inc. | IOBT | Sullivan Amy Chief Financial Officer | 55,000 | $0 | 55,000 (Direct) | View |
| 2023-03-20 Option Award | 2023-03-22 4:21 pm | N/A 2033-03-20 | IO Biotech Inc. | IOBT | Burkavage Brian Chief Accounting Officer | 50,000 | $0 | 50,000 (Direct) | View |
| 2023-03-20 Option Award | 2023-03-22 4:13 pm | N/A 2033-03-20 | IO Biotech Inc. | IOBT | Ehrnrooth Eva Chief Medical Officer | 120,000 | $0 | 120,000 (Direct) | View |
| 2023-01-12 Option Award | 2023-01-13 4:49 pm | N/A 2033-01-12 | IO Biotech Inc. | IOBT | Smith Devin Whittemore General Counsel | 150,000 | $0 | 150,000 (Direct) | View |
| 2022-10-17 Option Award | 2022-10-19 4:54 pm | N/A 2032-10-17 | IO Biotech Inc. | IOBT | Sullivan Amy Chief Financial Officer | 288,152 | $0 | 288,152 (Direct) | View |
| 2022-05-31 Option Award | 2022-06-02 6:25 pm | N/A 2032-05-31 | IO Biotech Inc. | IOBT | Burkavage Brian Chief Accounting Officer | 20,000 | $0 | 20,000 (Direct) | View |
| 2022-05-26 Option Award | 2022-05-31 7:42 pm | N/A 2032-05-26 | IO Biotech Inc. | IOBT | Hirth Peter Director | 23,885 | $0 | 23,885 (Direct) | View |
| 2022-05-26 Option Award | 2022-05-31 7:40 pm | N/A 2032-05-26 | IO Biotech Inc. | IOBT | Smith David V Director | 23,885 | $0 | 23,885 (Direct) | View |
| 2022-05-26 Option Award | 2022-05-31 7:39 pm | N/A 2032-05-26 | IO Biotech Inc. | IOBT | Glaub Kathleen Sereda Director | 23,885 | $0 | 23,885 (Direct) | View |